Philippe Lenoble
Presidente en Ducentis BioTherapeutics Ltd. .
Perfil
Philippe Lenoble is currently the Chairman at Ducentis BioTherapeutics Ltd., Director at Sintonia SpA, and Director at CFA Society of the UK.
He previously worked as a Research Assistant at Université Catholique de Louvain.
He completed his undergraduate degree at Université Catholique de Louvain.
Cargos activos de Philippe Lenoble
Empresas | Cargo | Inicio |
---|---|---|
Sintonia SpA
Sintonia SpA Investment ManagersFinance Sintonia SA operates as an investment holding company with interests in the infrastructure sector and mobility services. The company is headquartered in Treviso, Italy. | Director/Miembro de la Junta | - |
Ducentis BioTherapeutics Ltd.
Ducentis BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Ducentis Biotherapeutics Ltd. develops novel therapies for inflammation and autoimmune disease. The company was founded by Rebecca Ashfield, David Blackbourn and Philip Huxley in March 2015 and is headquartered in Witney, the United Kingdom. | Presidente | - |
CFA Society of the UK
CFA Society of the UK Miscellaneous Commercial ServicesCommercial Services CFA Society of the UK is an association of investment professionals based in the UK. The British company was founded in an unspecified year. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Philippe Lenoble.
Empresas | Cargo | Fin |
---|---|---|
Université Catholique de Louvain | Corporate Officer/Principal | - |
Formación de Philippe Lenoble.
Université Catholique de Louvain | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Sintonia SpA
Sintonia SpA Investment ManagersFinance Sintonia SA operates as an investment holding company with interests in the infrastructure sector and mobility services. The company is headquartered in Treviso, Italy. | Finance |
Ducentis BioTherapeutics Ltd.
Ducentis BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Ducentis Biotherapeutics Ltd. develops novel therapies for inflammation and autoimmune disease. The company was founded by Rebecca Ashfield, David Blackbourn and Philip Huxley in March 2015 and is headquartered in Witney, the United Kingdom. | Health Technology |
CFA Society of the UK
CFA Society of the UK Miscellaneous Commercial ServicesCommercial Services CFA Society of the UK is an association of investment professionals based in the UK. The British company was founded in an unspecified year. | Commercial Services |
- Bolsa de valores
- Insiders
- Philippe Lenoble